| Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine AJ Aguirre, JA Nowak, ND Camarda, RA Moffitt, AA Ghazani, ... Cancer discovery 8 (9), 1096-1111, 2018 | 306 | 2018 |
| Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location K Mima, Y Cao, AT Chan, ZR Qian, JA Nowak, Y Masugi, Y Shi, M Song, ... Clinical and translational gastroenterology 7 (11), e200, 2016 | 266 | 2016 |
| Tumour CD274 (PD-L1) expression and T cells in colorectal cancer Y Masugi, R Nishihara, J Yang, K Mima, A Da Silva, Y Shi, K Inamura, ... Gut 66 (8), 1463-1473, 2017 | 219 | 2017 |
| Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type AN Karnezis, Y Wang, P Ramos, WPD Hendricks, E Oliva, E D'Angelo, ... The Journal of pathology 238 (3), 389-400, 2016 | 206 | 2016 |
| Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer MB Yurgelun, AB Chittenden, V Morales-Oyarvide, DA Rubinson, ... Genetics in Medicine 21 (1), 213-223, 2019 | 186 | 2019 |
| Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma ZR Qian, DA Rubinson, JA Nowak, V Morales-Oyarvide, RF Dunne, ... JAMA oncology 4 (3), e173420-e173420, 2018 | 178 | 2018 |
| Dietary patterns and risk of colorectal cancer: analysis by tumor location and molecular subtypes RS Mehta, M Song, R Nishihara, DA Drew, K Wu, ZR Qian, TT Fung, ... Gastroenterology 152 (8), 1944-1953. e1, 2017 | 170 | 2017 |
| Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (vol 25, pg 1260, 2019) P Cejas, Y Drier, K Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ... NATURE MEDICINE 25 (10), 1627-1627, 2019 | 149* | 2019 |
| Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors P Cejas, Y Drier, KMA Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ... Nature medicine 25 (8), 1260-1265, 2019 | 149 | 2019 |
| Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors P Cejas, Y Drier, KMA Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ... Nature medicine 25 (8), 1260-1265, 2019 | 149 | 2019 |
| Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors P Cejas, Y Drier, KMA Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ... Nature medicine 25 (8), 1260-1265, 2019 | 149 | 2019 |
| Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors P Cejas, Y Drier, KMA Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ... Nature medicine 25 (8), 1260-1265, 2019 | 148 | 2019 |
| Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability StatusFusobacterium, MSI, and Immunity in Colorectal … T Hamada, X Zhang, K Mima, S Bullman, Y Sukawa, JA Nowak, K Kosumi, ... Cancer immunology research 6 (11), 1327-1336, 2018 | 146 | 2018 |
| Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status T Hamada, Y Cao, ZR Qian, Y Masugi, JA Nowak, J Yang, M Song, ... Journal of Clinical Oncology 35 (16), 1836, 2017 | 142 | 2017 |
| The prognostic role of macrophage polarization in the colorectal cancer microenvironment JP Väyrynen, K Haruki, MC Lau, SA Väyrynen, R Zhong, A Dias Costa, ... Cancer immunology research 9 (1), 8-19, 2021 | 108 | 2021 |
| A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors N Conlon, AM Schultheis, S Piscuoglio, A Silva, E Guerra, C Tornos, ... Modern Pathology 28 (12), 1603, 2015 | 104 | 2015 |
| Diets that promote colon inflammation associate with risk of colorectal carcinomas that contain Fusobacterium nucleatum L Liu, FK Tabung, X Zhang, JA Nowak, ZR Qian, T Hamada, D Nevo, ... Clinical Gastroenterology and Hepatology 16 (10), 1622-1631. e3, 2018 | 102 | 2018 |
| Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type N Conlon, A Silva, E Guerra, P Jelinic, BA Schlappe, N Olvera, JJ Mueller, ... The American journal of surgical pathology 40 (3), 395-403, 2016 | 101 | 2016 |
| Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type N Conlon, A Silva, E Guerra, P Jelinic, BA Schlappe, N Olvera, JJ Mueller, ... The American journal of surgical pathology 40 (3), 395-403, 2016 | 101 | 2016 |
| Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical OutcomeImmune Complexity in Pancreatic Cancer SM Liudahl, CB Betts, S Sivagnanam, V Morales-Oyarvide, A Da Silva, ... Cancer discovery 11 (8), 2014-2031, 2021 | 89 | 2021 |
Shuji OginoProf (Pathol & Epidemiol), Harvard; Broad Institute; Dana-Farber HCC Immunology Prog; MPE Chief, BWHVerified email at bwh.harvard.edu
